AWM
TECH icon

Angeles Wealth Management’s Bio-Techne TECH Stock Holding History

Angeles Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Sell
6,237
-843
-12% -$45.5K 0.02% 302
2026
Q1 		$370K Buy
7,080
+550
+8% +$33K 0.02% 283
2025
Q4 		$384K Buy
6,530
+827
+15% +$50.3K 0.02% 251
2025
Q3 		$317K Buy
5,703
+189
+3% +$10.1K 0.02% 248
2025
Q2 		$284K Buy
5,514
+1,464
+36% +$73.6K 0.02% 272
2025
Q1 		$237K Buy
4,050
+13
+0.3% +$881 0.02% 258
2024
Q4 		$291K Buy
4,037
+85
+2% +$6.24K 0.02% 219
2024
Q3 		$316K Buy
+3,952
New +$297K 0.03% 192

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Angeles Wealth Management's TECH Position: Q2 2026 in Review

Angeles Wealth Management reduced its Bio-Techne (TECH) stake by 12% in Q2 2026, selling an estimated $45.5K and leaving 6,237 shares worth $441K. The position accounts for 0.02% of the portfolio, ranked #302.

Angeles Wealth Management first reported a position in TECH in Q3 2024 and has held it in 8 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Angeles Wealth Management held 6,237 shares of Bio-Techne worth $441K as of Q2 2026.
  • Angeles Wealth Management sold 843 Bio-Techne shares in Q2 2026, an estimated $45.5K.
  • Bio-Techne made up 0.02% of Angeles Wealth Management's portfolio in Q2 2026, its #302 holding.
  • Angeles Wealth Management first reported a position in Bio-Techne in Q3 2024 and has held it in 8 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.